FutureChem Obtains Patent Related to Prostate Cancer Diagnosis
[Asia Economy Reporter Minwoo Lee] FutureChem announced on the 1st that it has obtained a patent for '18F-labeled compounds for prostate cancer diagnosis and their uses.' The company stated, "Compared to existing diagnostic methods, higher patient convenience and accurate diagnosis are expected," adding, "Currently, Phase 1 clinical trials are underway at the Korea Institute of Radiological & Medical Sciences, Seoul St. Mary's Hospital, and Johns Hopkins Hospital in the United States, and after filing patents in 16 countries worldwide, including Australia, the registration review is in progress."
Hot Picks Today
There Is a Distinct Age When Physical Abilities Decline Rapidly... From What Age Do Strength and Endurance Drop?
- Taking Annual Leave and Adding "Strike" to Profiles, "It Feels Like Samsung Has Collapsed"... Unsettled Internal Atmosphere
- Cerebras Soars 70% on IPO Debut: Is Nvidia's Reign Ending as a New AI Semiconductor Power Emerges?
- "After Vowing to Become No. 1 Globally, Sudden Policy Brake Puts Companies’ Massive Investments at Risk"
- On Teacher's Day, a Student's Gifted Cake Had to Be Cut into 32 Pieces... Why?
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
